Rychahou Piotr, Shu Yi, Haque Farzin, Hu Jiyao, Guo Peixuan, Evers B Mark
Markey Cancer Center, Department of Surgery, University of Kentucky, 800 Rose Street, CC140, 40536, Lexington, KY, USA.
Methods Mol Biol. 2015;1297:121-35. doi: 10.1007/978-1-4939-2562-9_9.
In recent years, RNA nanotechnology has become increasingly attractive due to its potential for applications in nanomedicine. RNA nanotechnology refers to the design and synthesis of nanoparticles composed mainly of RNA via bottom-up self-assembly. RNA nanoparticle is a suitable candidate for targeted delivery of therapeutics to cancer cells due to its multivalency, which allows the combination of therapeutic, targeting, and detection moieties all into one nanoparticle. To date, a system capable of exclusively targeting metastatic cancers that have spread to distant organs or lymph nodes is in demand. In this chapter, we report methods for establishing the clinically relevant colorectal cancer mouse metastasis models and describe methods and assays for constructing multifunctional, thermodynamically and chemically stable RNA nanoparticles that specifically target colorectal cancer metastases in the liver. Systemic injection of RNA nanoparticles showed metastatic cells targeting with little or no accumulation in normal liver parenchyma several hours after injection, demonstrating the therapeutic potential of these RNA nanoparticles as a delivery system for the treatment of cancer metastases.
近年来,RNA纳米技术因其在纳米医学中的应用潜力而变得越来越有吸引力。RNA纳米技术是指通过自下而上的自组装设计和合成主要由RNA组成的纳米颗粒。RNA纳米颗粒由于其多价性,是将治疗剂靶向递送至癌细胞的合适候选者,这使得治疗、靶向和检测部分都能结合在一个纳米颗粒中。迄今为止,需要一种能够专门靶向已扩散到远处器官或淋巴结的转移性癌症的系统。在本章中,我们报告了建立临床相关的结直肠癌小鼠转移模型的方法,并描述了构建特异性靶向肝脏中结直肠癌转移灶的多功能、热力学和化学稳定的RNA纳米颗粒的方法和检测方法。全身注射RNA纳米颗粒后数小时,显示出对转移细胞的靶向作用,而在正常肝实质中几乎没有或没有积累,证明了这些RNA纳米颗粒作为治疗癌症转移的递送系统的治疗潜力。